Kupczyk, D.; Studzińska, R.; Kołodziejska, R.; Baumgart, S.; Modrzejewska, M.; Woźniak, A.
11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases. J. Clin. Med. 2022, 11, 6190.
https://doi.org/10.3390/jcm11206190
AMA Style
Kupczyk D, Studzińska R, Kołodziejska R, Baumgart S, Modrzejewska M, Woźniak A.
11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases. Journal of Clinical Medicine. 2022; 11(20):6190.
https://doi.org/10.3390/jcm11206190
Chicago/Turabian Style
Kupczyk, Daria, Renata Studzińska, Renata Kołodziejska, Szymon Baumgart, Martyna Modrzejewska, and Alina Woźniak.
2022. "11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases" Journal of Clinical Medicine 11, no. 20: 6190.
https://doi.org/10.3390/jcm11206190
APA Style
Kupczyk, D., Studzińska, R., Kołodziejska, R., Baumgart, S., Modrzejewska, M., & Woźniak, A.
(2022). 11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases. Journal of Clinical Medicine, 11(20), 6190.
https://doi.org/10.3390/jcm11206190